1. 2327 Comparison between Child Pugh A5 vs A6 and ALBI grade 1 vs 2 in patients treated with sorafenib for HCC. (September 2015) Authors: Edeline, J.; Blanc, J.F.; Johnson, P.; Ross, P.; Ma, Y.T.; King, J.; Hubner, R.; Graham, J.; Darby, S.; Evans, J.; Iwuji, C.; Swinson, D.; Collins, P.; Patel, K.; Muazzam, I.; Palmer, D.; Meyer, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sorafenib for the Treatment of Advanced Hepatocellular Cancer – a UK Audit. Issue 4 (April 2017) Authors: King, J.; Palmer, D.H.; Johnson, P.; Ross, P.; Hubner, R.A.; Sumpter, K.; Darby, S.; Braconi, C.; Iwuji, C.; Swinson, D.; Collins, P.; Patel, K.; Nobes, J.; Muazzam, I.; Blesing, C.; Kirkwood, A.; Nash, S.; Meyer, T. Journal: Clinical oncology Issue: Volume 29:Issue 4(2017) Page Start: 256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗